GeniPhys Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$500K
- Investors
-
6
GeniPhys General Information
Description
Developer of a polymerizable collagen product designed to support site-appropriate tissue generation without evoking inflammation. The company's technology supports the custom design and fabrication of collagen materials for improvising tissue restoration and regeneration, enabling medical researchers to provide potential material applications that extend from regenerative tissue replacements to the delivery of pharmaceutical and cell-based therapies.
Contact Information
Website
www.geniphys.comCorporate Office
- 7750 Zionsville Road
- Suite 200
- Indianapolis, IN 46268
- United States
Corporate Office
- 7750 Zionsville Road
- Suite 200
- Indianapolis, IN 46268
- United States
GeniPhys Timeline
GeniPhys Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Grant | 22-Oct-2024 | $500K | Completed | Product Development | ||
8. Later Stage VC (Series A) | 14-Mar-2023 | Completed | Pre-Clinical Trials | |||
7. Accelerator/Incubator | 14-Apr-2022 | Completed | Pre-Clinical Trials | |||
6. Grant | 28-Feb-2022 | Completed | Pre-Clinical Trials | |||
5. Grant | 01-Jul-2019 | Completed | Pre-Clinical Trials | |||
4. Early Stage VC | 10-Jan-2017 | Completed | Pre-Clinical Trials | |||
3. Early Stage VC | 19-May-2015 | Completed | Pre-Clinical Trials | |||
2. Early Stage VC (Series A) | $100K | $100K | Completed | Pre-Clinical Trials | ||
1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GeniPhys Patents
GeniPhys Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230131204-A1 | High-strength collagen compositions and methods of use | Pending | 31-Mar-2020 | ||
CA-3175543-A1 | High-strength collagen compositions and methods of use | Pending | 31-Mar-2020 | ||
EP-4125777-A1 | High-strength collagen compositions and methods of use | Pending | 31-Mar-2020 | ||
EP-4125777-A4 | High-strength collagen compositions and methods of use | Pending | 31-Mar-2020 | ||
CA-3168904-A1 | Biologic filler for restoring and regenerating tissue | Pending | 27-Jan-2020 | A61L27/502 |
GeniPhys Signals
GeniPhys Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Pier 70 Ventures | Venture Capital | Minority | ||
MedTech Innovator | Accelerator/Incubator | |||
National Science Foundation | Government | |||
Elevate Ventures | Venture Capital | Minority | ||
Purdue Research Foundation | Limited Partner |
GeniPhys FAQs
-
When was GeniPhys founded?
GeniPhys was founded in 2014.
-
Where is GeniPhys headquartered?
GeniPhys is headquartered in Indianapolis, IN.
-
What is the size of GeniPhys?
GeniPhys has 8 total employees.
-
What industry is GeniPhys in?
GeniPhys’s primary industry is Discovery Tools (Healthcare).
-
Is GeniPhys a private or public company?
GeniPhys is a Private company.
-
What is GeniPhys’s current revenue?
The current revenue for GeniPhys is
. -
How much funding has GeniPhys raised over time?
GeniPhys has raised $6.2M.
-
Who are GeniPhys’s investors?
Pier 70 Ventures, MedTech Innovator, National Science Foundation, Elevate Ventures, and Purdue Research Foundation are 5 of 6 investors who have invested in GeniPhys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »